Dr. Saag has received consulting fees and/or honoraria (less than $10,000) and grant support from Amgen. Dr. Kramer has served as a consultant to the FDA in designing, analyzing, and interpreting a study on heart failure associated with tumor necrosis factor inhibitors and has received consulting fe
Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor
β Scribed by Winthrop, Kevin L
- Book ID
- 121482842
- Publisher
- Nature Publishing Group
- Year
- 2006
- Tongue
- English
- Weight
- 170 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1745-8382
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective To assess the association between the initiation of antiβtumor necrosis factor Ξ± (antiβTNFΞ±) therapy and the risk of serious bacterial infections in routine care. ## Methods This was a cohort study of patients with rheumatoid arthritis (RA) in whom specific diseaseβmodif
## Abstract ## Objective To evaluate the risk of serious bacterial infections associated with tumor necrosis factor Ξ± (TNFΞ±) antagonists among rheumatoid arthritis (RA) patients. ## Methods A retrospective cohort study of US RA patients enrolled in a large health care organization identified pat